Avastin Gains New Ovarian Cancer Indication
FDA has approved Avastin (bevacizumab) in combination with chemotherapy for the treatment of platinum-resistant, recurrent ovarian cancer.
Diagnosis & Disease Information
Patients Readmitted Within 1 Month of Ovarian Cancer Surgery Have Increased 1-Year Mortality
Significant association between 30-day hospital readmission following surgery for advanced ovarian cancer and 1-year mortality.
Not Enough Women Screened for Cervical Cancer
CDC notes that more than half of cervical cancer cases occur among women never or rarely screened.
Tamoxifen Plus Ovarian Function Suppression Increases Menopausal Symptoms and Sexual Dysfunction
Tamoxifen + ovarian function suppression cause more menopausal symptoms and sexual dysfunction compared with tamoxifen alone.
Researchers Identify Mutation That May Serve as a Biomarker for Colorectal, Endometrial Cancers
A new mutation has been identified in colorectal and endometrial cancers that may potentially serve as a biomarker.
Hospice Care Has No Effect on Terminal Ovarian Cancer Treatment
Findings among older patients with terminal ovarian cancer receiving hospice care.
For Patients with Ovarian Cancer at End of Life, Paradoxical Increase in Use of Intensive Medical Services and Hospice
Despite an increase in the use of hospice, the use of costly services for patients with ovarian cancer also increased.
Patients Undergoing Oophorectomy Benefit from Half-Day Educational Program
Half-day educational program can successfully help women deal with issues caused by an oophorectomy.
Ovarian Cancer Gene Mutation Found in Vaginal Fluid
Preliminary finding of vaginal fluid may bring doctors one step closer to test for ovarian cancer in early stages.
For HER2-Positive Uterine Serous Carcinoma, Afatinib May Be Effective
Afatinib caused uterine serous carcinoma tumors to shrink.
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...